HDAC inhibitors block innate immunity

被引：19

作者：

Bode, Konrad A. ^{[1
]}

Dalpke, Alexander H. ^{[1
]}

机构：

[1] Univ Heidelberg, D-6900 Heidelberg, Germany

来源：

BLOOD | 2011年 / 117卷 / 04期

关键词：

HISTONE DEACETYLASE INHIBITOR; SUBEROYLANILIDE HYDROXAMIC ACID; CANCER;

D O I：

10.1182/blood-2010-11-315820

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：1102 / 1103

页数：4

共 11 条

[1]

Histone deacetylase inhibitors decrease Toll-like receptor-mediated activation of proinflammatory gene expression by impairing transcription factor recruitment [J].

Bode, Konrad A. ;

Schroder, Kate ;

Hume, David A. ;

Ravasi, Timothy ;

Heeg, Klaus ;

Sweet, Matthew J. ;

Dalpke, Alexander H. .

IMMUNOLOGY, 2007, 122 (04) :596-606

[2]

Histone deacetylase activities are required for innate immune cell control of Th1 but not Th2 effector cell function [J].

Brogdon, Jennifer L. ;

Xu, Yongyao ;

Szabo, Susanne J. ;

An, Shaojian ;

Buxton, Francis ;

Cohen, Dalia ;

Huang, Qian .

BLOOD, 2007, 109 (03) :1123-1130

[3]

Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma [J].

Duvic, Madeleine ;

Vu, Jenny .

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (07) :1111-1120

[4]

Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll-like receptor 4 agonist LPS [J].

Halili, Maria A. ;

Andrews, Melanie R. ;

Labzin, Larisa I. ;

Schroder, Kate ;

Matthias, Gabriele ;

Cao, Chun ;

Lovelace, Erica ;

Reid, Robert C. ;

Le, Giang T. ;

Hume, David A. ;

Irvine, Katharine M. ;

Matthias, Patrick ;

Fairlie, David P. ;

Sweet, Matthew J. .

JOURNAL OF LEUKOCYTE BIOLOGY, 2010, 87 (06) :1103-1114

[5]

NFκB:: Linking inflammation and immunity to cancer development and progression [J].

Karin, M ;

Greten, FR .

NATURE REVIEWS IMMUNOLOGY, 2005, 5 (10) :749-759

[6]

Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer [J].

Kelly, WK ;

O'Connor, OA ;

Krug, LM ;

Chiao, JH ;

Heaney, M ;

Curley, T ;

MacGregore-Cortelli, B ;

Tong, W ;

Secrist, JP ;

Schwartz, L ;

Richardson, S ;

Chu, E ;

Olgac, S ;

Marks, PA ;

Scher, H ;

Richon, VM .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (17) :3923-3931

[7]

A phosphorylation-acetylation switch regulates STAT1 signaling [J].

Kraemer, Oliver H. ;

Knauer, Shirley K. ;

Greiner, Georg ;

Jandt, Enrico ;

Reichardt, Sigrid ;

Guehrs, Karl-Heinz ;

Stauber, Roland H. ;

Boehmer, Frank D. ;

Heinzel, Thorsten .

GENES & DEVELOPMENT, 2009, 23 (02) :223-235

[8]

The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines [J].

Leoni, F ;

Zaliani, A ;

Bertolini, G ;

Porro, G ;

Pagani, P ;

Pozzi, P ;

Donà, G ;

Fossati, G ;

Sozzani, S ;

Azam, T ;

Bufler, P ;

Fantuzzi, G ;

Goncharov, I ;

Kim, SH ;

Pomerantz, BJ ;

Reznikov, LL ;

Siegmund, B ;

Dinarello, CA ;

Mascagni, P .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (05) :2995-3000

[9]

Selective and antagonistic functions of SWI/SNF and Mi-2β nucleosome remodeling complexes during an inflammatory response [J].

Ramirez-Carrozzi, VR ;

Nazarian, AA ;

Li, CC ;

Gore, SL ;

Sridharan, R ;

Imbalzano, AN ;

Smale, ST .

GENES & DEVELOPMENT, 2006, 20 (03) :282-296

[10]

Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection [J].

Roger, Thierry ;

Lugrin, Jerome ;

Le Roy, Didier ;

Goy, Genevieve ;

Mombelli, Matteo ;

Koessler, Thibaud ;

Ding, Xavier C. ;

Chanson, Anne-Laure ;

Reymond, Marlies Knaup ;

Miconnet, Isabelle ;

Schrenzel, Jacques ;

Francois, Patrice ;

Calandra, Thierry .

BLOOD, 2011, 117 (04) :1205-1217

← 1 2 →